GOLDMAN SACHS GROUP INC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$10,866,917
+11.2%
732,272
+2.2%
0.00%0.0%
Q1 2024$9,769,745
+20.2%
716,257
-3.5%
0.00%
+100.0%
Q4 2023$8,125,645
+21.8%
742,068
+21.8%
0.00%0.0%
Q3 2023$6,670,871
-21.7%
609,212
-5.4%
0.00%
-50.0%
Q2 2023$8,522,125
+42.9%
643,665
+46.9%
0.00%
+100.0%
Q1 2023$5,962,663
-28.4%
438,109
+2.7%
0.00%
-50.0%
Q4 2022$8,329,760
+127149.6%
426,511
+24.1%
0.00%0.0%
Q3 2022$6,546
-22.7%
343,601
-16.4%
0.00%0.0%
Q2 2022$8,468
-99.9%
411,071
+124.5%
0.00%
+100.0%
Q1 2022$5,893,000
+7.9%
183,141
+56.1%
0.00%0.0%
Q4 2021$5,462,000
+15.4%
117,304
-33.1%
0.00%0.0%
Q3 2021$4,733,000
+52.2%
175,284
+44.5%
0.00%0.0%
Q2 2021$3,110,000
+36.7%
121,274
+82.2%
0.00%0.0%
Q1 2021$2,275,000
+10.9%
66,551
+9.7%
0.00%0.0%
Q4 2020$2,051,000
+214.6%
60,659
+129.5%
0.00%
Q3 2020$652,00026,4320.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$36,261,51317.78%
Saturn V Capital Management LP 636,158$8,422,7324.67%
MPM BioImpact LLC 1,745,943$23,116,2854.66%
Boxer Capital, LLC 2,154,058$28,5201.32%
RA Capital Management 4,417,259$58,484,5091.10%
Octagon Capital Advisors LP 596,000$7,891,0401.10%
BVF INC/IL 1,810,835$23,975,4550.67%
683 Capital Management, LLC 585,000$7,745,4000.56%
AlphaCentric Advisors LLC 63,000$834,1200.46%
DAFNA Capital Management LLC 98,560$1,304,9340.36%
View complete list of ITEOS THERAPEUTICS INC shareholders